Infratil lifts CDC outlook and FY27 earnings guidance

The Infratil Ltd (ASX: IFT) share price is in focus today after the company increased its EBITDAF guidance for 2027 and announced progress in expanding data centre operations.

What did Infratil report?

• Upgraded FY27 EBITDAF guidance to A$680–$720 million (previously ~A$660 million)
• FY26 EBITDAF expected at lower end of A$390–$400 million, due to timing of contracted capacity
• A$500 million equity raise completed to support accelerated growth at CDC
• Bank debt upsizing to A$2.1 billion expected by March 2026
• Strong pipeline with 18 operational CDC data centres and five under construction

What else do investors need to know?

CDC, Infratil’s Australasian data centre business, continues to benefit from robust demand for secure, large-scale data centre infrastructure—especially supporting AI and cloud workloads. Two new data centres at CDC’s Eastern Creek campus are nearing operational status, which will significantly boost available capacity.

The business maintains its position as the largest data centre operator in Australasia, with market-leading water efficiency thanks to closed-loop cooling systems. Minimal water use has enabled CDC to add almost 200 megawatts of capacity in the latest quarter, while maintaining environmental credentials.

What did Infratil management say?

Infratil CEO Jason Boyes commented:

Our focus is on supporting CDC to deliver more capacity to meet the growing demand for data centre space across Australasia. Infratil, along with CDC’s other major shareholders, recently provided A$500 million in equity funding to support the acceleration of CDC’s construction programme.

What’s next for Infratil?

Looking ahead, Infratil plans to keep expanding CDC’s footprint, meeting ongoing demand for secure data centre capacity across Australia and New Zealand. The higher formal EBITDAF guidance for FY27 reflects management’s confidence in CDC’s strong contract pipeline and expectations for continued growth in digital infrastructure.

Investment in skills and sustainable technology will remain a priority, alongside developing new sites and supporting the transition to clean energy.

Infratil share price snapshot

Over the past 12 months, Infratil shares have declined 6%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 7% over the same period.

View Original Announcement

The post Infratil lifts CDC outlook and FY27 earnings guidance appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Thursday
• Here are the top 10 ASX 200 shares today
• Metrics Master Income Trust announces March 2026 distribution
• ASX 200 jumps as inflation surprises to the downside
• Sims Group posts robust US growth through SA Recycling in FY26

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.